Patent ID: 11926619
Assignee: EISAI R&D MANAGEMENT CO., LTD
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 14:
15. A method of treating cancer in a subject in need thereof, comprising administering to said subject a therapeutically effective amount of a compound and/or pharmaceutically acceptable salt according to any one of claims 1, 5, 6, 8, 9, and 10, or a pharmaceutical composition comprising a compound and/or pharmaceutically acceptable salt according to any one of claims 1, 5, 6, 8, 9, and 10; and at least one additional therapy; wherein the cancer is chosen from myelodysplastic syndrome, chronic lymphocytic leukemia, acute lymphoblastic leukemia, chronic myelomonocytic leukemia, acute myeloid leukemia, colon cancer, pancreatic cancer, endometrial cancer, ovarian cancer, breast cancer, uveal melanoma, gastric cancer, cholangiocarcinoma, and lung cancer.